SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing intense downward pressure as investors grow increasingly skeptical of its high valuation and the looming threat of significant insider share unlocks. The community is sharply divided, with many retail traders bracing for further declines toward double digits, while some bargain hunters are cautiously scouting for entry points amidst the ongoing sell-off.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors react to mixed earnings results featuring a revenue and EPS beat alongside full-year guidance that fell short of expectations. The community is sharply divided, with bulls pointing to robust enterprise demand and strong fundamentals, while bears are focused on the guidance miss and the broader rotation of capital out of the SaaS sector.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently the focal point of market volatility as investors weigh a record delivery report against concerns over margin compression and the company's aggressive capital expenditures in AI and robotics. The community remains deeply polarized, with active debate centered on whether upcoming product roadmaps and potential synergies with other ventures justify the current valuation or if imminent earnings results will force a significant downward revaluation.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors scrutinize its massive AI-driven capital expenditures and cloud segment performance against high quarterly expectations. While the community is actively debating the sustainability of the company's AI spending and its competitive positioning, much of the sentiment remains focused on whether recent product rollouts and cloud momentum can justify further valuation expansion.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is capturing significant market attention as investors brace for earnings, with intense debate centering on whether the company's aggressive AI infrastructure spending will drive future cloud dominance or simply weigh on margins. The community remains deeply divided, with bulls highlighting Google's AI leadership and cloud growth, while skeptics are warning that lofty market expectations could trigger a sharp sell-off if capital expenditure guidance disappoints.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending ahead of its upcoming earnings report as investors and community members closely monitor the company's progress on manufacturing scalability and potential commercialization updates. Discussions are intensely focused on whether recent partnerships, such as the one with Honda, will provide tangible catalysts to shift the stock's recent downward momentum, with traders actively debating the impact of institutional positioning and sector-wide macro headwinds.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath Inc. is experiencing heightened volatility and massive trading volume as the community debates whether the activity signals institutional accumulation or ongoing market manipulation. Investors are fixated on the stock's significant short interest, with many hoping that a breakout above key resistance levels will trigger a potential short squeeze.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is seeing high volatility and heavy trader attention after a recent profit warning triggered a significant sell-off, prompting intense community debate over whether the stock is now deeply oversold or facing long-term structural decay. While bears point to shifting enterprise IT budgets, bulls are actively targeting a recovery, highlighting the company's dividend stability, quantum computing pipeline, and potential for a short squeeze following the recent liquidation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to heightened anticipation ahead of the upcoming FDA advisory committee meeting on July 29th, with investors bracing for volatility as they await crucial briefing documents. The community is actively debating the likelihood of a broad label approval versus a narrow cardiomyopathy-only indication, while simultaneously managing concerns over patent litigation and short-selling activity.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing massive trading volume and heightened investor interest following a string of defense and autonomous technology orders totaling millions in contract value. The community is actively debating the stock's potential for a short squeeze, with many pointing to the elevated cost-to-borrow fees and strong bullish sentiment ahead of upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mike Garrison to Retire from BD

Mike Garrison to Retire from BD Mike Garrison to Retire from BD PR Newswire FRANKLIN LAKES, N.J., July 22, 2026 FRANKLIN LAKES, N.J., July 22, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike...

BD to Announce Financial Results for its Third Quarter of Fiscal 2026

BD to Announce Financial Results for its Third Quarter of Fiscal 2026 BD to Announce Financial Results for its Third Quarter of Fiscal 2026 PR Newswire FRANKLIN LAKES, N.J., July 9, 2026 FRANKLIN LAKES,N.J., July 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...

Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?

WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.

How Are Emerging Markets Supporting Abbott's EPD Momentum?

ABT's Emerging Markets drive EPD growth, with strong branded generics demand, biosimilar expansion and new approvals boosting momentum. 

BD Awarded Vizient Innovative Technology Contract for CentroVena One Insertion System

BD Awarded Vizient Innovative Technology Contract for CentroVena One Insertion System BD Awarded Vizient Innovative Technology Contract for CentroVena One Insertion System PR Newswire FRANKLIN LAKES, N.J., June 23, 2026 Recognition from Vizient validates CentroVena One as a breakthrough innovation...

How to Approach Abbott Stock Following Its Sharp YTD Decline?

ABT falls 29.4% YTD as respiratory testing weakness, China uncertainty and acquisition dilution pressure results and outlook.

Here's Why You Should Retain BDX Stock in Your Portfolio Now

Becton, Dickinson's MedTech focus, innovation push and strategic partnerships support growth optimism, though reimbursement uncertainty remains a key concern.

How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026

ABT's Diagnostics unit witnesses mixed Q1 results as Core Lab growth offsets China weakness and softer respiratory testing demand.

BD Launches Elyra Thulium Fiber Laser System for Kidney Stone Care

BDX launches the Elyra Thulium Fiber Laser system to streamline kidney stone care and boost workflow flexibility for urology teams.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton Dickinson & Co.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$153.16
Prev Close	$153.84
Open	$154.87
Dividend Yield	2.22%
50-Day Moving Average	$149.14
Beta	0.47
Avg. Volume	2.91M
PE Ratio	39.01

52-Week High	$187.35
52-Week Low	$127.54
Market Capitalization	$42.39B
EPS (Annual)	$5.82
Price to Book	1.76
Revenue Per Employee	$303,333.33

Feed

News

Sentiment

Earnings

Fundamentals

Info

BDXBecton, Dickinson And Co.

Latest BDX News